SequelSEC

Tilray Brands, Inc. TLRY

Medicinal Chemicals & Botanical Products · CIK 0001731348 · Fiscal year ends 0531

Revenue
$915.45M
Fiscal year ended 2026-05-31
Operating income
-$63.03M
Fiscal year ended 2026-05-31
Free cash flow
Unavailable
Fiscal year ended 2026-05-31

Tilray Brands, Inc. (TLRY) reported revenue of $915.45M and net income of -$121.40M for the fiscal year ended 2026-05-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Tilray Brands, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Medicinal Chemicals & Botanical Products.

Income

Tilray Brands, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-05-31
Revenue$915.45M
Cost of revenue$655.01M
Gross profit$260.44M
Operating income-$63.03M
Net income-$121.40M
Research & development$361.00K
Weighted-average diluted sharesUnavailable
Pretax income-$88.06M
Income tax expense$17.10M
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$203.63M
Selling & marketingUnavailable

Balance

Tilray Brands, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-05-31
Cash & equivalents$225.98M
Total assets$2.33B
Current assets$792.13M
Total liabilities$733.14M
Current liabilities$358.38M
Total equity incl. NCI$1.59B
Temporary (mezzanine) equityUnavailable
Inventory$301.19M
Accounts receivable$189.17M
Goodwill$752.35M
Long-term debtUnavailable
Accounts payable$114.54M

Cash flow

Tilray Brands, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-05-31
Operating cash flow-$69.14M
Capital expendituresUnavailable
Investing cash flow-$55.80M
Financing cash flow$130.99M
Net change in cash$7.68M
Stock-based compensation$45.94M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

Tilray Brands, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-05-31
Free cash flowUnavailable
Gross margin28.4%
Operating margin-6.9%
FCF marginUnavailable
SBC / revenue5.0%
Current ratio2.21x
Revenue YoY growth11.5%
Net margin-13.3%
R&D / revenue0.0%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open TLRY in the interactive workspace to inspect any figure back to its filing.

Source filings

10-K · Filed 2026-07-28View SEC filing
10-Q · Filed 2026-04-01View SEC filing
10-Q · Filed 2026-01-08View SEC filing
10-Q · Filed 2025-10-09View SEC filing
10-K · Filed 2025-07-29View SEC filing
10-Q · Filed 2025-04-08View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.